Ads
related to: jazz pharmaceuticals- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Antibody Science
Explore Our Unique Platforms
For Creating Antibody Treatments.
- Careers
Search results
Goldman starts Jazz at buy, cites diversified portfolio (NASDAQ:JAZZ)
Seeking Alpha· 20 hours agoGoldman Sachs initiated coverage of Jazz Pharmaceuticals (JAZZ) with a buy rating, citing its...
Goldman Sachs says buy this biotech stock with more than 60% upside
CNBC· 20 hours agoIt's time for investors to buy the dip on Jazz Pharmaceuticals , according to Goldman Sachs. The...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
WLNS Lansing· 5 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase ...
Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 6 days agoA month has gone by since the last earnings report for Jazz Pharmaceuticals (JAZZ). Shares have lost...
Here are Wednesday's biggest analyst calls: Apple, Nvidia, Amazon, Meta, Uber, Disney, Coinbase,...
CNBC· 23 hours agoHere are Wednesday's biggest calls on Wall Street: BMO initiates Old Dominion as outperform BMO said...
ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
FierceBiotech· 5 days agoAs zanidatamab awaits an FDA approval decision, Jazz Pharmaceuticals is sharing
Instacart, Boston Beer upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 22 hours agoGoldman Sachs initiated coverage of Jazz Pharmaceuticals (JAZZ) with a Buy rating and $169 price...
STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML
MedPage Today· 6 days agoThe STAMP inhibitor asciminib (Scemblix) had a statistically superior response rate compared with...
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For...
Benzinga· 23 hours agoFor a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst Subbu Nambi initiated coverage on Twist ...
7 Overlooked Stocks Offering Long-Term Stability From the Shadows
InvestorPlace· 3 days agoWhile you can screen for micro-caps, pink sheet stocks, and similar speculative investments, most of...